NYU School of Medicine
New York, New York, United States
Since fellowship, my career goals have centered on understanding the pathogenesis, treatments, and outcomes of systemic lupus erythematosus (SLE) and neonatal lupus (NL). I have trained with Dr. Jill Buyon, chief of the division of Rheumatology at NYU School of Medicine, director of the NYU Lupus Center and director of the national Research Registry for Neonatal Lupus (RRNL). In order to attain skills necessary to maximize my ability to design and perform translational research I attained a Masters in Clinical Investigation via the NYU CTSI. I have also gained experience with a large research registry, extracting and analyzing data that has been used for several publications and presentations. Since 2013, I have led the clinical trials team in SLE at NYU, acting as principal investigator on multiple industry, NIH sponsored and investigator initiated interventional and observational trials, and am well versed in all lupus clinical assessment tools and have transitioned to specializing in the care of lupus patients after completing a Pfizer fellowship in Rheumatology/Immunology focused on SLE. In addition I currently direct the Clinical Trial Design course for the NYU CTSI Masters in Clinical Investigation program.
Sunday, November 17, 2024
10:30 AM – 12:30 PM Eastern Time
No financial relationships with ineligible companies to disclose
17S38: CARE to Test Your Knowledge: Lupus Nephritis
Sunday, November 17, 2024
2:15 PM – 3:15 PM Eastern Time
Disclosure(s): AbbVie: Advisor or Review Panel Member (Terminated, March 15, 2023); AstraZeneca: Advisor or Review Panel Member (Ongoing); Aurinia: Consultant (Ongoing); Bristol-Myers Squibb(BMS): Dinner (Terminated, November 11, 2023); GSK: Advisor or Review Panel Member (Terminated, March 16, 2022); Synthekine: Consultant (Ongoing)